Evolus Inc (EOLS) Stock Price, Quote, News & History

EOLSNASDAQ
$5.30
-0.01-0.19%
At close: Apr 24, 5:00 PM EST
$5.31
0.010.19%
After Hours: 9:30 AM EST
Earnings: Q1 2026 Earnings in 10 days from now on Mon May 4th, after the market close

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-42.27M
Investing Cash Flow (TTM)
-8.45M
Financing Cash Flow (TTM)
17.34M
Free Cash Flow (TTM)
-50.72M
Capital Expenditure (TTM)
-8.45M
Net Change in Cash (TTM)
-33.38M

Analyst Trends and Forecast

1
Dec 25
3
Jan
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$446.64M
PE Ratio (TTM)
-
PE Ratio (FWD)
53.19
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.15
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-15.07%
Earnings Yield % (FWD)
1.88%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.36

Company Debt

Total Debt
$146.10M
LT Debt
$146.10M
LT Debt Issuance (TTM)
$25.00M
LT Debt Repayment (TTM)
-$15.00K
Total Cash
$53.83M
Debt to Equity
-
Issuance of Debt (TTM)
$24.99M
Repayment of Debt (TTM)
-$15.00K

Key Statistics

Open
$5.29
Close
$5.30
Volume / Avg.
830.96K / 1.11M
Day Range
$5.20 - $5.52
52 Wk Range
3.86 - 12.28
Market Cap
$344.19M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
66
Short Interest
10.27%
Days to Cover
6.57

About

Sector
Health Care
Industry
Pharmaceuticals
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and inje...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Evolus (EOLS) stock?

A

You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Evolus (EOLS) stock?

A

Evolus has a consensus price target of $17.50.

Q

What is the current price for Evolus (EOLS)?

A

The stock price for Evolus (NASDAQ: EOLS) is $5.31 last updated April 24, 2026 at 9:30 AM EDT.

Q

Does Evolus (EOLS) pay a dividend?

A

There are no upcoming dividends for Evolus.

Q

When is Evolus (NASDAQ:EOLS) reporting earnings?

A

Evolus does not have any upcoming earnings scheduled.

Q

Is Evolus (EOLS) going to split?

A

There is no upcoming split for Evolus.

Q

What sector and industry does Evolus (EOLS) operate in?

A

Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.